Nov 4, 2026
2-day lag
Sale
Nov 2, 2026
Common Stock
Crystal Adam
President, R&d
1,100 shares @ $22.99
Direct ownership
$25.29K
SEC Form 4
›
Same filing as the row above
Exercise
Nov 2, 2026
Stock Option (Right to Buy) on Common Stock
5,000 shares @ $0
Direct ownership
$0
›
Same filing as the row above
Sale
Nov 2, 2026
Common Stock
3,900 shares @ $22.26
Direct ownership
$86.82K
›
Same filing as the row above
Exercise
Nov 2, 2026
5,000 shares @ $2.91
Direct ownership
$14.55K
›
Nov 4, 2026
2-day lag
Award
Nov 2, 2026
Restricted Stock Unit on Common Stock
Grech Patricia Y
SVP, Chief Accounting Officer
4,806 shares @ $0
Direct ownership
$0
SEC Form 4
›
Nov 4, 2026
2-day lag
Sale
Nov 2, 2026
Common Stock
Newcomb Jessica
Principal Accounting Officer
1,460 shares @ $22.98
Direct ownership
$33.55K
SEC Form 4
›
Same filing as the row above
Sale
Nov 2, 2026
5,571 shares @ $22.28
Direct ownership
$124.11K
›
Nov 4, 2026
1-day lag
Sale
Nov 3, 2026
Common Stock
Moran John V
Chief Financial Officer
19,261 shares @ $25.57
Direct ownership
$492.5K
SEC Form 4
›
Nov 4, 2026
1-day lag
Sale
Nov 3, 2026
Common Stock
Maduck Sean
Other
8,617 shares @ $82.02
Direct ownership
$706.76K
SEC Form 4
›
Same filing as the row above
Exercise
Nov 3, 2026
Stock option (right to buy) on Common Stock
13,159 shares @ $0
Direct ownership
$0
›
Same filing as the row above
Sale
Nov 3, 2026
Common Stock
4,542 shares @ $82.68
Direct ownership
$375.51K
›
Same filing as the row above
Exercise
Nov 3, 2026
13,159 shares @ $8.27
Direct ownership
$108.82K
›
Same filing as the row above
Sale
Nov 2, 2026
11,841 shares @ $81.42
Direct ownership
$964.07K
›
Same filing as the row above
Exercise
Nov 2, 2026
Stock option (right to buy) on Common Stock
11,841 shares @ $0
Direct ownership
$0
›
Same filing as the row above
Exercise
Nov 2, 2026
Common Stock
11,841 shares @ $8.27
Direct ownership
$97.93K
›
Nov 4, 2026
2-day lag
Sale
Nov 2, 2026
Common Stock
Kleinerman Christian
EVP, Product Management
10,000 shares @ $306.01
Direct ownership
$3.06M
SEC Form 4
›
Nov 4, 2026
2-day lag
Sale
Nov 2, 2026
Common Stock
Vieira Roberto Wandenkolk
President, Oncology
6,657 shares @ $80.73
Direct ownership
$537.44K
SEC Form 4
›
Same filing as the row above
Exercise
Nov 2, 2026
8,333 shares @ $21.63
Direct ownership
$180.24K
›
Same filing as the row above
Sale
Nov 2, 2026
1,676 shares @ $81.52
Direct ownership
$136.63K
›
Same filing as the row above
Exercise
Nov 2, 2026
Stock option (right to buy) on Common Stock
8,333 shares @ $0
Direct ownership
$0
›
Nov 4, 2026
2-day lag
Sale
Nov 2, 2026
Class A-1 Common Stock
Phelan Mark T.
President And CEO
25,000 shares @ $12
Direct ownership
$300K
SEC Form 4
›
Nov 4, 2026
2-day lag
Sale
Nov 2, 2026
Common Stock
Anschutz Barron
Other
10,000 shares @ $51
Direct ownership
$510K
SEC Form 4
›
Nov 4, 2026
2-day lag
Exercise
Nov 2, 2026
Stock Option (right to buy) on Common Stock
Seawell A Brooke
Director
115,000 shares @ $0
Direct ownership
$0
SEC Form 4
›
Same filing as the row above
Sale
Nov 2, 2026
Common Stock
15,000 shares @ $48.73
Indirect ownership
$730.95K
›
Same filing as the row above
Sale
Nov 2, 2026
15,000 shares @ $50.33
Direct ownership
$754.95K
›